Glycemic Gravity: The Pull of HbA1c on Balanoposthitis Severity.

Background Balanoposthitis, an inflammatory condition of the glans penis and foreskin, is common in diabetic patients, especially those with poor glycemic control. Chronic hyperglycemia, as measured by HbA1c, may exacerbate the severity of balanoposthitis. Limited research exists on the direct relationship between HbA1c and disease severity, making this link crucial to understand for better management. Aim The primary aim was to evaluate the correlation between HbA1c and balanoposthitis severity in diabetic males. Objectives included assessing severity by HbA1c levels, exploring the impact of glycemic control on symptom progression, and providing clinical insights for treatment improvement. Materials and methods This was a cross-sectional study involving a sample size of 50 diabetic male patients diagnosed with balanoposthitis. HbA1c was measured using standard laboratory tests. Disease severity was assessed using a Clinical Severity Scoring System, where symptoms including erythema, edema, discharge, and ulceration were individually scored from 0 (none) to 3 (severe or purulent or multiple deep ulcers). The total severity score ranged from 0 to 24, with a higher score indicating more severe disease. Data analysis involved Pearson's correlation and regression analysis. Patients were grouped by glycemic control as good (HbA1c ≤ 6%), moderate (HbA1c 7 to 8%), and poor (HbA1c ≥ 9%). Key findings The distribution of patients showed that the largest group, 44%, had poor glycemic control (HbA1c ≥ 9%) and presented with severe balanoposthitis (score 13-24). Thirty-six percent of patients had moderate control (HbA1c 7-8%) with moderate balanoposthitis (score 7-12), and 20% had good control (HbA1c ≤ 6%) with mild symptoms (score 0-6). Symptom prevalence and intensity increased significantly with higher HbA1c levels. For patients with poor control (HbA1c ≥ 9%), the prevalence of severe symptoms was high: 90% experienced erythema, 85% experienced itching, edema, and painful burning sensation, and 75% had ulceration. In contrast, patients with good control (HbA1c ≤ 6%) primarily experienced mild symptoms such as itching (30%) and erythema (40%), with ulceration present in only 5%. The statistical analysis showed a strong positive correlation between HbA1c levels and balanoposthitis severity, with a Pearson's correlation coefficient (r) of 0.45 (p < 0.01). This indicates that as HbA1c increases, severity scores rise significantly. Poor glycemic control was associated with higher severity, including ulceration and pain, whereas good control was linked to mild symptoms. Conclusions and clinical relevance HbA1c levels strongly correlate with balanoposthitis severity. Glycemic control is essential for preventing progression to severe symptoms. Early intervention and management of blood glucose can reduce symptom severity and may prevent severe cases. This study highlights the clinical relevance of integrating endocrinology and dermatology, advocating for a holistic approach and collaboration between dermatologists, endocrinologists, and primary care providers for effective management and improved early diagnosis and treatment.